Related by context. All words. (Click for frequent words.) 67 carboplatin paclitaxel 66 cyclophosphamide 66 Peg IFN 66 fluorouracil 66 gemcitabine chemotherapy 66 dacarbazine 65 5FU 65 gemcitabine 65 docetaxel Taxotere 64 vinorelbine 64 idarubicin 64 cytarabine 64 azathioprine 64 plus dexamethasone 64 docetaxel 64 paclitaxel 64 cisplatin gemcitabine 64 FOLFIRI 64 plus prednisone 63 capecitabine 63 cisplatin 63 temsirolimus 63 neoadjuvant chemotherapy 63 Fludara 63 VELCADE melphalan 63 #mg/m# [001] 63 carboplatin 63 epirubicin 63 docetaxel chemotherapy 62 azacitidine 62 estramustine 62 6 mercaptopurine 62 Gemcitabine 62 hepatic metastases 62 melphalan prednisone 62 FOLFOX 62 Irinotecan 62 5 Fluorouracil 62 CHOP chemotherapy 62 piperacillin tazobactam 62 dose dexamethasone 62 bevacizumab 62 paclitaxel Taxol 62 chemoradiotherapy 62 lopinavir r 62 etoposide 62 sorafenib Nexavar 62 topotecan 62 5 fluorouracil 62 Melphalan 62 alfa 2a 61 FOLFOX4 61 doxorubicin 61 paclitaxel chemotherapy 61 interferon alfa 2a 61 pegylated liposomal doxorubicin 61 nab paclitaxel 61 mitomycin 61 5-FU/LV 61 oblimersen 61 5 FU 61 refractory multiple myeloma 61 neoadjuvant 61 chlorambucil 61 paclitaxel Taxol ® 61 adriamycin 61 decitabine 61 TACE 61 fludarabine cyclophosphamide 61 metastatic renal cell carcinoma 61 paclitaxel carboplatin 61 fluoropyrimidine 61 gemcitabine carboplatin 61 prednisone VcMP 61 DOXIL 61 gemcitabine cisplatin 61 mitoxantrone 61 pegylated interferon alfa 2a 61 ritonavir boosted 60 Pegasys peginterferon alfa 2a 60 dacarbazine DTIC 60 sorafenib Nexavar ® 60 chemoradiation 60 dose cytarabine 60 pemetrexed 60 doxorubicin cyclophosphamide 60 trastuzumab 60 dexamethasone 60 radiochemotherapy 60 PegIFN 60 ixabepilone 60 abacavir lamivudine 60 mycophenolate mofetil 60 interferon alfa 2b 60 azacytidine 60 Platinol 60 interferon alfa 60 bortezomib 60 daunorubicin 60 temozolomide 60 refractory NSCLC 60 cisplatin chemotherapy 60 sunitinib malate 60 cyclophosphamide chemotherapy 60 5 FU leucovorin 60 mg/m2 60 bevacizumab Avastin ® 60 Cytoxan 60 Tarceva TM 60 leucovorin 60 low dose cytarabine 60 mRCC 59 dexamethasone Decadron 59 mcg kg 59 concurrent chemoradiation 59 docetaxel Taxotere R 59 plus gemcitabine 59 epirubicin cyclophosphamide 59 milatuzumab 59 FUSILEV enhances 59 pegylated interferon alfa 59 saline placebo 59 chemotherapeutic agents 59 mg m² 59 Doxil ® 59 unresectable 59 GP IIb IIIa inhibitors 59 erlotinib Tarceva ® 59 lenalidomide dexamethasone 59 mapatumumab 59 relapsed refractory multiple myeloma 59 pegylated interferon alfa 2b 59 Taxol ® 59 cytotoxic chemotherapy 59 CIMZIA TM 59 vandetanib 59 #mg/m# [002] 59 monotherapy 59 Neoadjuvant 59 sorafenib 59 free survival PFS 59 q8h 59 peg IFN 59 oral allopurinol 59 trastuzumab Herceptin R 59 sorafenib tablets 59 refractory AML 59 heavily pretreated patients 59 Platinol ® cisplatin 59 bortezomib Velcade R 59 paclitaxel Taxol R 59 docetaxel Taxotere ® 59 5 fluorouracil leucovorin 59 Torisel 59 Cloretazine 59 intravenous bolus 59 trabectedin 58 chemotherapeutic regimen 58 chemoradiation therapy 58 bendamustine 58 Imprime PGG 58 #mg/kg [002] 58 Taxotere ® 58 Folfox 58 Alkeran 58 cyclophosphamide Cytoxan 58 Taxotere R 58 fluticasone 58 receptor tyrosine kinase inhibitor 58 Flu Cy 58 ACTEMRA TM 58 advanced unresectable 58 vorinostat 58 Pegasys ® 58 median PFS 58 boosted protease inhibitor 58 clodronate 58 cetuximab 58 cyclophosphamide methotrexate 58 cisplatin vinorelbine 58 untreated multiple myeloma 58 dose melphalan 58 eribulin mesylate 58 autologous stem cell 58 erlotinib 58 TPV r 58 Platinol ® 58 bevacizumab Avastin 58 relapsed multiple myeloma 58 mg/m2 administered 58 Carboplatin 58 telaprevir dosed 58 ribavirin RBV 58 taxane chemotherapy 58 cetuximab Erbitux ® 58 IV bolus 58 chemoembolization 58 levofloxacin 58 VIDAZA 58 Lenalidomide 58 4mg/kg 58 Capecitabine 58 liposomal formulation 58 postoperative chemotherapy 58 PREZISTA r 58 neoadjuvant treatment 57 standard chemotherapy regimen 57 pegfilgrastim 57 Taxotere docetaxel 57 plus ribavirin 57 G CSF 57 low dose dexamethasone 57 follicular NHL 57 cyclophosphamide doxorubicin vincristine 57 Xcytrin 57 fludarabine 57 gemcitabine Gemzar 57 amphotericin B 57 MGd 57 TAXOTERE R 57 #mg BID [003] 57 TORISEL 57 BEACOPP 57 peginterferon alfa 2b 57 bevacizumab Avastin R 57 Gliadel Wafer 57 Pemetrexed 57 HER2 positive metastatic breast 57 octreotide LAR 57 EBRT 57 xenograft models 57 Chemophase 57 beclomethasone dipropionate 57 chemotherapeutic drug 57 continuous intravenous infusion 57 Erlotinib 57 FIRMAGON 57 8mg/kg 57 VELCADE 57 Cyclophosphamide 57 chemotherapy docetaxel 57 peginterferon alfa 2a 57 amrubicin 57 gemcitabine Gemzar ® 57 stage IIIb IV 57 Camptosar ® 57 rituximab 57 mg m 57 external beam radiotherapy 57 MabCampath 57 chemotherapy cisplatin 57 vinca alkaloids 57 administered subcutaneously 57 mg QD 57 IFN alfa 57 amprenavir 57 epoetin alfa 57 irinotecan 57 taxane 57 Paclitaxel 57 lenalidomide 57 mesalamine 57 XELOX 57 Bezielle 57 biologic DMARD 57 LEXIVA r 57 dasatinib Sprycel ® 57 IXEMPRA 57 comparator arm 57 adecatumumab 57 lapatinib Tykerb 57 oral rivaroxaban 57 remission induction 57 Etoposide 57 Q2W 57 mg/m2/day 57 FOLFOX6 57 platinum refractory 57 tacrolimus 57 tipranavir 57 infusional 5-FU/LV 57 alkylating agent 56 chemotherapeutic regimens 56 Ceplene/IL-2 56 pegylated interferon 56 Cisplatin 56 immunosuppressant 56 Mitoxantrone 56 SCH # 56 q#h 56 EFAPROXYN 56 aspirin heparin 56 paclitaxel poliglumex 56 μg dose 56 intravesical 56 tirofiban 56 Hycamtin ® 56 letrozole Femara 56 adalimumab Humira 56 5mg/kg 56 Cyclosporine 56 CA4P 56 Aeroquin 56 irinotecan doxorubicin oxaliplatin paclitaxel 56 oxaliplatin 56 pomalidomide 56 cangrelor 56 PEG IFN 56 Halaven 56 unfractionated heparin 56 non squamous histology 56 fallopian tube carcinoma 56 nicardipine 56 Amrubicin 56 intravesical instillation 56 Herceptin trastuzumab 56 cytarabine daunorubicin 56 placebo dexamethasone 56 irinotecan chemotherapy 56 stage IIIB 56 Fludara ® 56 active comparator 56 recurrent NSCLC 56 Elitek 56 irbesartan 56 vincristine 56 BCG refractory 56 nucleoside analog 56 cyclophosphamide vincristine 56 Copegus ribavirin 56 Docetaxel 56 oral clodronate 56 VAPRISOL 56 thrombolytics 56 pamidronate 56 chemotherapy regimens 56 colorectal liver metastases 56 intravitreal injection 56 CD# antibody [001] 56 adjuvant 56 HGS# 56 octreotide 56 relapsed MM 56 thalidomide Thalomid 56 capecitabine Xeloda 56 Tarceva erlotinib 56 metastatic RCC 56 relapsing multiple sclerosis 56 budesonide 56 ELOXATIN 56 doxorubicin docetaxel 56 goserelin 56 Oxaliplatin 56 titrated glipizide 56 sunitinib 56 PEGINTRON 56 Teriflunomide 56 temozolomide TMZ 56 MYLOTARG 56 ZACTIMA 56 recurrent GBM 56 Peginterferon alfa 2b 56 #mg QD [002] 56 zalutumumab 56 Pegasys R 56 FOLPI 56 anthracycline taxane 56 ABVD 56 Bortezomib 56 mg subcutaneous 56 nadolol 56 Vandetanib 55 Xeloda ® 55 bolus dose 55 Vidaza ® 55 injected subcutaneously 55 plus prednisone prednisolone 55 tenecteplase 55 Xanafide 55 tyrosine kinase inhibitor 55 PEGASYS ® 55 radiofrequency ablation RFA 55 refractory cutaneous T 55 Elacytarabine 55 zoledronic acid 55 GW# [003] 55 abiraterone acetate 55 visilizumab 55 subcutaneously administered 55 R sorafenib tablets 55 refractory chronic lymphocytic 55 cyclophosphamide doxorubicin 55 alpha 2a 55 metastatic colorectal carcinoma 55 DMARDs 55 mg/m2 dose 55 REBETOL 55 lenalidomide Revlimid R 55 budesonide pMDI 55 PREZISTA ritonavir 55 paclitaxel cisplatin 55 Allovectin 7 ® 55 HERCEPTIN 55 pegylated interferon alpha 55 antithymocyte globulin 55 Trastuzumab 55 fluorouracil leucovorin 55 superficial bladder cancer 55 mycophenolate mofetil MMF 55 neoadjuvant therapy 55 stavudine d4T 55 Bevacizumab 55 preoperative chemotherapy 55 Alocrest 55 Peginterferon 55 chemotherapy FOLFOX 55 PEG interferon 55 radiotherapy RT 55 intra arterial 55 cetuximab Erbitux R 55 mcg BID 55 Rituxan rituximab 55 resectable 55 subconjunctival injection 55 Cotara 55 distant metastases 55 potent CYP#A# inhibitors 55 IIIa inhibitor 55 fluconazole 55 TO AVOID PREGNANCY WHILE 55 ara C 55 ASCT 55 Ribavirin 55 FOLFOX chemotherapy 55 chemotherapy regimen 55 dimeglumine 55 ketorolac 55 Doxorubicin 55 rizatriptan 55 cisplatin carboplatin 55 Free Survival PFS 55 pertuzumab 55 nitazoxanide 55 selective antagonist 55 intratumoral injection 55 refractory indolent non 55 locoregional recurrence 55 Leucovorin 55 Aptivus ® 55 orBec 55 dacarbazine chemotherapy 55 arsenic trioxide injection 55 antitumor activity 55 VNP#M 55 metastatic GIST 55 TEMODAL 55 infliximab monotherapy 55 Vicinium TM 55 intradermal injection 55 pegylated interferon alpha 2a 55 taxanes 55 TREDAPTIVE 55 methylprednisolone 55 omega interferon 55 microbiological eradication 55 CorVue ™ 55 mitoxantrone plus 55 adjuvant chemotherapy 55 peg interferon 55 Paraplatin ® 55 partial remissions 55 chemotherapeutic agent 55 Navelbine ® 55 Pharmacokinetics PK 55 liposomal doxorubicin 55 carboplatin chemotherapy 55 interferon beta 1a 55 candesartan cilexetil 55 standard chemotherapy regimens 55 NRTIs 55 unresectable locally advanced 55 immunomodulatory therapy 55 metastatic CRC 55 peginterferon 55 granisetron 55 PEG Intron 55 dosed orally 55 adalimumab 55 Hodgkin lymphoma NHL 55 mg kg dose 55 dasatinib 55 carmustine 55 tiotropium 55 Taxotere 55 Cremophor 55 TELINTRA 55 timolol 55 degarelix 55 peginterferon alfa 2a Pegasys 55 Neupogen ® 55 plus 5-FU/LV 55 monoclonal antibody conjugated 54 teriflunomide 54 INC# 54 refractory acute myeloid 54 L asparaginase 54 calcineurin inhibitors 54 evaluating REVLIMID 54 cyclosporine 54 administered orally 54 Doxil 54 IFN α 54 Eli Lilly Gemzar 54 PI3K inhibitor 54 mitomycin C 54 gefitinib Iressa 54 cell lymphoma CTCL 54 administered intravenously 54 REYATAZ R 54 CIMZIA ™ 54 interferon ribavirin 54 taxotere 54 pyrazinamide 54 Mycophenolate Mofetil 54 chemotherapeutics 54 doxorubicin HCl liposome injection 54 subcutaneously injected 54 edoxaban 54 chemotherapy gemcitabine 54 oral beclomethasone dipropionate 54 comparator PI r 54 sunitinib Sutent 54 pharmacologically active isomer 54 Pegylated Liposomal Doxorubicin 54 Gemzar ® 54 Jevtana 54 gefitinib 54 rituximab Rituxan ® 54 TNFerade 54 flutamide 54 mTOR inhibitor 54 insulin glulisine 54 CHOP cyclophosphamide doxorubicin vincristine 54 FOLFOX4 alone 54 mg BID 54 advanced hepatocellular carcinoma 54 leukemia CLL 54 TTF Therapy 54 nucleoside analogue 54 demonstrated antitumor activity 54 bleomycin 54 dosage regimens 54 IMGN# 54 mg TID 54 sirolimus eluting stent 54 metastatic gastric 54 ciclesonide 54 Panzem R NCD 54 salmeterol fluticasone 54 Sorafenib 54 fibrinolytic 54 vincristine adriamycin 54 APTIVUS r 54 neratinib 54 Taxotere chemotherapy 54 liver metastases 54 locoregional 54 rituximab refractory 54 VIRAMUNE 54 trastuzumab Herceptin 54 insulin glargine 54 hA# 54 CoFactor 54 capecitabine Xeloda R 54 cytoreductive surgery 54 intravenous bisphosphonates 54 recombinant tissue plasminogen 54 Vidaza azacitidine 54 Velcade bortezomib 54 posaconazole 54 glycoprotein IIb IIIa inhibitor 54 ULORIC 54 intravenously administered 54 FOLFOX regimen 54 Mitomycin C 54 Pegintron 54 platelet inhibitor 54 nilotinib 54 Zorbtive TM 54 cidofovir 54 iodixanol 54 Darunavir 54 YONDELIS 54 subcutaneously 54 oral antidiabetic 54 fluticasone salmeterol 54 Azacitidine 54 Fludarabine 54 adjuvant therapy 54 TroVax ® 54 diagnosed multiple myeloma 54 insulin detemir 54 Dapagliflozin 54 tenofovir Viread 54 alpha 2b 54 relapsed refractory 54 sunitinib Sutent ® 54 angiotensin receptor blocker ARB 54 darunavir ritonavir 54 mcg albinterferon alfa 2b 54 debulking surgery 54 oral ribavirin 54 microwave hyperthermia 54 dasatinib Sprycel 54 Taxol paclitaxel 54 relapsed SCLC 54 reteplase 54 cilengitide 54 intravesical infusion therapy 54 unfractionated heparin UFH 54 dose regimens 54 weekly subcutaneous injections 54 TYKERB 54 subcutaneous injections 54 lenalidomide Revlimid ® 54 CANCIDAS 54 Telintra 54 Pertuzumab 54 carfilzomib 54 idraparinux 54 calcineurin inhibitor 54 gemtuzumab ozogamicin 54 Gemzar gemcitabine 54 parecoxib 54 DORIBAX 54 DOXIL ® 54 FOLFIRI alone 54 APTIVUS R 54 unresectable Stage III 54 sirolimus 54 budesonide formoterol 54 oral Xeloda 54 KRAS mutant tumors 54 subcutaneous SC 54 mutated KRAS 54 QD dosing 54 #Gy 54 Gefitinib 54 mg qd 54 prednisone 54 relapsed CLL 54 veltuzumab 54 bivalirudin 54 ARIKACE 54 anti leukemic 54 cabazitaxel 54 AKT inhibitor 54 voriconazole 54 oral chemotherapeutic agent 54 dabigatran etexilate 54 factor Xa inhibitor 54 BARACLUDE ® 54 mCi kg 54 leukotriene receptor antagonist 54 mcg QD 54 alpha interferons 54 achieved ACR# 54 lapatinib 54 lung metastases 54 metastatic sarcoma 54 unresectable tumors 54 surrogate endpoint 53 COPEGUS 53 AVASTIN 53 LPV r 53 evaluating Xcytrin 53 intravenous REOLYSIN 53 Pegasys plus Copegus 53 aflibercept 53 plus DOXIL 53 FOLFOX6 chemotherapy regimen 53 novel emulsion formulation 53 Vidofludimus 53 metformin sulfonylurea 53 PEGylated Fab fragment 53 xanthine oxidase inhibitor 53 lamivudine 53 metastatic hormone refractory 53 Fluorouracil 53 metastatic pancreatic cancer 53 histone deacetylase HDAC inhibitor 53 vinca alkaloid 53 PREZISTA rtv 53 relapsed myeloma 53 leukemia AML 53 intramuscularly 53 #Y ibritumomab tiuxetan 53 epoprostenol 53 3mg/kg 53 HER2 negative 53 advanced metastatic renal 53 severe neutropenia 53 tiotropium bromide 53 peginterferon alpha 2a 53 dexamethasone VAD 53 Xeloda capecitabine 53 TNF alpha inhibitor 53 CsA 53 INTELENCE 53 rituximab Rituxan 53 sorafenib Nexavar R 53 Omacetaxine 53 epoetin alpha 53 regorafenib 53 YERVOY 53 Temozolomide 53 darbepoetin alfa 53 sipuleucel T 53 denileukin diftitox 53 achieved PASI 53 interferon alpha 53 tamsulosin 53 dalteparin 53 efavirenz EFV 53 Ixempra 53 non squamous NSCLC 53 receiving VICTRELIS 53 lamivudine 3TC 53 Darusentan 53 histamine dihydrochloride 53 CR nPR 53 camptothecin 53 doublet chemotherapy 53 IMiDs 53 TNF antagonists 53 mometasone furoate 53 systemic absorption 53 Sandostatin R 53 LMWH 53 alfa 2b 53 ribavirin Copegus ® 53 Adjuvant chemotherapy 53 REVLIMID lenalidomide 53 etanercept 53 infusional 53 Saizen R 53 potent triglyceride lowering 53 cediranib 53 LANTUS R 53 ® lenalidomide 53 axitinib 53 EOquin 53 Temsirolimus 53 galiximab 53 thromboembolic events 53 adjuvant radiation 53 Interferon alfa 53 Lapatinib 53 bolus injection 53 biochemical relapse 53 heavily pretreated 53 SCIg 53 corticosteroid dexamethasone 53 bronchodilation 53 evaluating tivozanib 53 tobramycin 53 Epirubicin 53 Rituxan MabThera 53 rFSH 53 peginterferon alfa 53 mCRC patients 53 fosamprenavir 53 tenofovir emtricitabine 53 plus COPEGUS 53 pancreatic adenocarcinoma 53 febrile neutropenia 53 PEGINTRON TM 53 ascending doses 53 trans retinoic acid ATRA 53 erlotinib Tarceva 53 Clolar ® 53 certolizumab 53 immunoconjugate 53 rt PA 53 oral anticoagulant 53 vinorelbine tartrate 53 abciximab 53 kilogram mg kg 53 metastatic malignant 53 SCCHN 53 Nexavar ® 53 rosuvastatin #mg 53 nucleoside reverse transcriptase inhibitor 53 neostigmine 53 DAPT 53 intravenous dosing 53 fallopian tube cancers 53 glufosfamide 53 targeted radiotherapeutic 53 formoterol fumarate 53 dose ritonavir 53 MAGE A3 ASCI 53 EGFR TKI 53 Combination therapy 53 recurrent glioblastoma multiforme 53 Surgical resection 53 Dabigatran etexilate 53 clofarabine 53 doripenem 53 tipranavir r 53 HSCT 53 Voreloxin 53 μg kg 53 neurologic progression 53 liposomal amphotericin B 53 BENICAR 53 tinzaparin 53 Kivexa 53 talabostat 53 cyclosporin 53 subcutaneous formulation 53 CCyR 53 cytotoxic 53 IMP# 53 ethambutol 53 relapsed ovarian cancer 53 tenofovir disoproxil fumarate 53 Pazopanib 53 selective orally bioavailable 53 nonmetastatic 53 angiotensin converting enzyme inhibitor 53 lanreotide 53 pioglitazone HCl 53 ritonavir boosted atazanavir 53 TAXUS Stent 53 Fulvestrant 53 APTIVUS 53 bupivacaine 53 adjuvant cisplatin 53 taxol 53 FluCAM 53 prednisone prednisolone plus 53 mcg doses 53 metastatic colorectal cancer 53 chemotherapies 53 docetaxel cisplatin 53 SUTENT 53 BAY #-# 53 ONCASPAR 53 satraplatin 53 plus dacarbazine 53 Resten NG 53 inhaled antibiotic 53 leuprolide 53 fluticasone furoate 53 potentially hepatotoxic 53 Topotecan 53 Avastin bevacizumab 52 motesanib 52 gastrointestinal stromal tumors 52 sapacitabine 52 metastatic pancreatic 52 CD4 monoclonal antibody 52 Caelyx 52 paricalcitol 52 mg kg 52 intravitreal 52 imatinib Gleevec ® 52 Sandostatin LAR 52 imatinib 52 mcg dose 52 intravenous cyclophosphamide 52 imipenem 52 adefovir dipivoxil 52 aprepitant 52 oral ridaforolimus 52 nebulization 52 care regimens CCR 52 microtubule inhibitor 52 Pegylated Interferon 52 IMA# 52 HGS ETR1 52 HDACi 52 infliximab 52 pharmacodynamic properties 52 STELARA 52 darunavir r 52 long acting muscarinic 52 imetelstat 52 TRILIPIX 52 generation purine nucleoside 52 alkylating agents 52 daily Infergen 52 Votrient 52 glargine 52 ceftazidime 52 #mg/day [001] 52 ORAL HYCAMTIN 52 immunosuppressive regimen 52 oral antidiabetic medication 52 oral prodrug 52 overlapping toxicities 52 relapsed acute myelogenous 52 Revascor TM 52 low dose ritonavir 52 hypofractionated 52 vancomycin 52 assessing T DM1 52 nilotinib Tasigna ® 52 ibritumomab tiuxetan 52 IV NSCLC 52 metastatic NSCLC 52 PegIntron 52 mg subcutaneously 52 ug kg 52 Faslodex 52 #mg doses [002] 52 adjuvant tamoxifen 52 Arixtra 52 deferoxamine 52 monotherapies 52 tumor xenograft models 52 CTAP# Capsules 52 Median PFS 52 mg/m2 IV 52 ganciclovir 52 viral kinetics 52 Diffuse Large B 52 eribulin 52 fenofibric acid 52 HBeAg positive patients 52 LCP Tacro TM 52 #mg BID [001] 52 ZYVOX 52 Intravenous CP 52 dosing regimens 52 plus methotrexate 52 ISF# 52 mg ustekinumab 52 subcutaneous enoxaparin 52 oral levofloxacin 52 allogeneic SCT 52 methotrexate MTX 52 Orally administered 52 recurrent metastatic 52 TAFA# 52 raltegravir 52 lispro 52 dose interleukin 52 somatostatin analogues 52 Telavancin 52 Rituximab 52 DMARDS 52 oxycodone IR 52 progression TTP 52 Xelox 52 dihydrochloride 52 zidovudine lamivudine 52 pegylated interferon peg IFN 52 mitoxantrone chemotherapy 52 temsirolimus Torisel ® 52 Median survival 52 cytotoxic agents 52 radiation chemoradiation 52 subcutaneous dosing 52 ropivacaine 52 anti angiogenic agent 52 #mg dose [001] 52 miconazole 52 signal transduction inhibitor 52 entecavir 52 EGFR expressing mCRC 52 Vidaza 52 mometasone 52 HBeAg seroconversion 52 sustained virologic response 52 raloxifene Evista 52 enfuvirtide 52 azilsartan medoxomil 52 RAPAFLO 52 trastuzumab Herceptin ® 52 nucleoside analogs 52 COPEGUS ribavirin 52 Gleevec imatinib 52 Neulasta ® 52 bosutinib 52 adefovir 52 beta2 agonist 52 hypercalcemia 52 Sanofi Aventis Taxotere 52 esomeprazole 52 DMARD 52 DexaSite 52 Hycamtin 52 aflibercept VEGF Trap 52 ciclosporin 52 virus HCV protease inhibitor 52 steroid dexamethasone 52 OPAXIO